You have 9 free searches left this month | for more free features.

City

Philadelphia (2)

Baltimore (1)

Condition

22q11.2 Deletion Syndrome (1)

Attention Deficit Disorder With Hyperactivity (1)

Attention-deficit Hyperactivity Disorder (ADHD) (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 1 (2)

phase 2/phase 3 (1)

Sponsor

Aevi Genomic Medicine, LLC, a Cerecor company (3)

Collaborator

Children's Hospital of Philadelphia (1)

Pearson/Clinical Assessment (1)

Thomas Jefferson University (1)

Intervention

nfc-1 (3)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

nfc-1

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

22q11.2 Deletion Syndrome Trial in Philadelphia (NFC-1)

Completed

22q11.2 Deletion Syndrome

NFC-1

Philadelphia, Pennsylvania

Children's Hospital of Philadelphia

Mar 24, 2022

Attention Deficit Disorder With Hyperactivity Trial in Baltimore (NFC-1, Placebo)

Completed

Has Results

Attention Deficit Disorder With Hyperactivity

NFC-1
Placebo

Baltimore, Maryland

The Clinical Trials Center at Kennedy Krieger Institute

Aug 2, 2021

Attention-deficit Hyperactivity Disorder (ADHD) Trial in Philadelphia (NFC-1)

Completed

Attention-deficit Hyperactivity Disorder (ADHD)

NFC-1

Philadelphia, Pennsylvania

Thomas Jefferson University, Clinical Research Unit

Dec 22, 2016